Bufalin Suppresses Head and Neck Cancer Development by Modulating Immune Responses and Targeting the β-Catenin Signaling Pathway

Nour Mhaidly(University of Mons), Géraldine Descamps(University of Mons)
Cancers
August 1, 2024
Cited by 4


Related Papers